A sample portfolio · NVDA, AAPL, MSFT, TSLA

Check your own stocks ↓

2 of your 4 prices assume more growth than the company has delivered.

And 3 of them, Apple, Microsoft and NVIDIA, ride one bet: spending by Anthropic, AT&T Inc. and 4 more. Each stock counts the same here; add your amounts after you save it.

A lot to go right · 2Below its record · 2

What each price is betting on

The yearly revenue growth the price needs, against the company's last three years and the analysts.

Where your money sits, by sector

Each stock counted the same, like the shared bets.

  • Technology · 3 stocks (NVDA, AAPL, MSFT)75%

  • Consumer Cyclical · 1 stock (TSLA)25%

One bet, 3 stocks

Spending by Anthropic, AT&T Inc. and 4 more

AAPL, MSFT and NVDA sell to the same customers, so 75% of this list moves on one question: do those companies keep spending?

  • Anthropic
  • AT&T Inc.
  • Advanced Micro Devices, Inc.
  • Alphabet Inc.
  • Amazon.com, Inc.
  • Ant

The case against your most stretched price

TSLA: Growth disappoints and margins stay thin

The price needs 52% a year; Tesla grew 2.5% a year over the last three. Car revenue keeps shrinking and services are too small to offset it, while energy revenue has already turned down. Once building slows, the cash margin stays below today's upkeep-only level and returns on capital stay near the bottom of peers. High rates and market fear keep the valuation under pressure. In the bear story a share is worth about $41, against $346 today.

See both sides on the TSLA page

Change the list · Share this check-up: the link holds the tickers, nothing about you.Evidence, not advice. Figures from the public stock pages.

Portfolio check-up · free · no account

What are your stocks betting on?

Type 3 to 5 stocks you own. In a few seconds you see the growth each price assumes, which of them ride the same bet, and the strongest case against the most stretched one.

S&P 500 stocks for now · funds are shown as funds

Every figure comes from Parra's public stock pages, updated every weekday. It is evidence, not advice: nothing here says whether to buy or sell.